血清白细胞介素-33在中枢神经系统疾病中的研究进展

Abstract
Figure/Table
References (29)
Related Citation (15)

Download: PDF (0 KB) HTML (38 KB)
Export: BibTeX | EndNote (RIS)

Abstract Interleukin-33 (IL-33),as an inflammatory factor,plays an important role in diseases of cardiovascular system,digestive system,respiratory system,tumors and other diseases,especially in the central nervous system,which is the current hot spot.However,the function of IL-33 in some diseases of central nervous system remains controversial.This review explained the pathogenesis,latest research advances,the potential prediction and therapeutic value of IL-33 in kinds of central nervous system diseases (4 types of intracranial infection,2 kinds of cerebrovascular disease,cognitive impairment,depression and glioma were included) through consulting a lot of literature.

Key words： Interleukin-33 Central nervous system diseases Inflammatory factor Clinical value

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	CHEN Zhen-lei
	QIN Xin-yue

Cite this article:

CHEN Zhen-lei,QIN Xin-yue. Research progress of serum interleukin-33 in central nervous system diseases[J]. 中国当代医药, 2020, 27(30): 27-30.

URL:

https://www.dangdaiyiyao.com/EN/ OR https://www.dangdaiyiyao.com/EN/Y2020/V27/I30/27

[27]	赵晓楠.IL-33在REM 睡眠剥夺小鼠认知功能损伤中的作用及其相关机制的初步研究[D].天津：天津医科大学，2019.
[28]	罗鹏.IL-33在脑胶质瘤中的表达及其与胶质瘤瘤周水肿的相关性研究[D].南充：川北医学院，2019.
[6]	Griesenauer B，Paczesny S.The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases[J].Front Immunol，2017，8：475.
[8]	黄小燕，戴小波，许坚锋，等.联合检测IL-33、MMP-9、PCT 在病毒性颅内感染中的诊断及鉴别诊断价值研究[J].国际检验医学杂志，2019，40（12）：1643-1646.
[15]	张蕾，刘挺挺，叶辛，等.IL-33在隐球菌脑膜炎患者外周血单个核中的表达及临床意义[J].现代检验医学杂志，2016，31（2）：29-31.
[20]	秘勇建，盖洁，江渔，等.蛛网膜下腔出血后脑血管痉挛发生机制及治疗的研究进展[J].中华脑血管病杂志（电子版），2013，7（4）：49-52.
[1]	Okunishi K，Wang Hao，Suzukawa M，et al.Exophilin-5 regulates allergic airway inflammation by controlling IL-33-mediated Th2 responses[J].J Clin Invest，2020，130（7）：3919-3935.
[2]	Pusceddu I，Dieplinger B，Mueller T.ST2 and the ST2/IL-33 signalling pathway-biochemistry and pathophysiology in animal models and humans[J].Clin Chim Acta，2019，495：493-500.
[3]	Zharichenko N，Njoku DB.The Role of Pro-Inflammatory and Regulatory Signaling by IL-33 in the Brain and Liver：A Focused Systematic Review of Mouse and Human Data and Risk of Bias Assessment of the Literature[J].Int J Mol Sci，2020，21（11）：3933.
[4]	Schmitz J，Owyang A，Oldham E，et al.IL-33，an interleukin-1-like cytokine that signals via the IL-1 receptorrelated protein ST2 and induces T helper type 2-associated cytokines[J].Immunity，2005，23（5）：479-490.
[5]	Eissmann MF，Buchert M，Ernst M.IL33 and Mast Cells-The Key Regulators of Immune Responses in Gastrointestinal Cancers[J].Front Immunol，2020，11（7）：1389.
[7]	Jones LA，Roberts F，Nickdel MB，et al.IL-33 receptor（T1/ST2）signalling is necessary to prevent the develipment of en-cephalitis in mice infected with Tpxoplasm godii[J].Eur J Immunol，2010，40（2）：426-436.
[9]	Kim AR，Park J，Kim JH，et al.Herpes Zoster DNA Vaccines with IL-7 and IL-33 Molecular Adjuvants Elicit Protective T Cell Immunity[J].Immune Netw，2018，18（5）：e38.
[10]	Zhou Z，Yan F，Liu O.Interleukin （IL）-33：an orchestrator of immunity from host defence to tissue homeostasis[J].Clin Transl Immunology，2020，9（6）：e1146.
[11]	Espinassous Q，Garcia-de-Paco E，Garcia-Verdugo I，et al.IL-33 enhances lipopolysaccharide-induce inflammatory cytokine production from mouse macrophages by regulating lipopolysaccha-ride reseptor complex[J].J Immunol，2009，183（2）：1446-1455.
[12]	Palomo J，Reverchon F，Piotet J，et al.Critical role of IL-33 receptor ST2 in experimental cerebral malaria development[J].Eur J Immunol，2015，45（5）：1354-1365.
[13]	Besnard AG，Guabiraba R，Niedbala W，et al.IL-33-Mediated Protection against Experimental Cerebral Malaria Is Linked to Induction of Type 2 Innate Lymphoid Cells，M2 Macrophages and Regulatory T Cells[J].PLoS Pathog，2015，11（2）：e1004607.
[22]	崔洪雨，施梅.首发抑郁症患者血清IL-33 水平与认知功能的相关研究[J].精神医学杂志，2019，32（1）：15-17.
[24]	刘铮，魏成喜.阿尔兹海默症的发病机制探究[J].世界最新医学信息文摘（电子版），2019，19（8）：170-171.
[26]	李军，姚静，王国芳，等.IL-33 对阿尔茨海默病模型大鼠脑组织内β-淀粉样蛋白的清除作用及其机制[J].吉林大学学报（医学版），2018，44（5）：750-754.
[14]	Gibson JF，Johnston SA.Immunity to Cryptococcus neoformans and C.gattii during cryptococcosis[J].Fungal Genet Biol，2015，78（5）：76-86.
[16]	Guo S，Luo Y.Brain Foxp3+ regulatory T cells can be expanded by Interleukin-33 in mouse ischemic stroke[J].Int Immunopharmacol，2020，81（4）：106 027.
[17]	Li XM，Wang XY，Feng XW，et al.Serum interleukin-33 as a novel marker for long-term prognosis and recurrence in acute ischemic stroke patients[J].Brain Behav，2019，9（9）：e01369.
[18]	Greenhalgh AD，Brough D，Robinson EM，et al.Interleukin-1 receptor antagonist is beneficial after subarachnoid haemorrhage in rat by blocking haem-driven inflammatory pathology[J].Dis Model Mech，2012，5（6）：823-833.
[19]	Barnes J，Mondelli V，Pariante CM.Genetic Contributions of Inflammation to Depression[J].Neuropsychopharmacology，2017，42（1）：81-98.
[21]	Kudinova AY，Deak T，Hueston CM，et al.Cross-species evidence for therole of interlrukin-33 in depression risk[J].J Abnorm Psychol，2016，125（4）：482-494.
[23]	Xiong Z，Thangavel R，Kempuraj D，et al.Alzheimer′s disease：evidence for the expression of interleukin-33 and its receptor ST2 in the brain[J].J Alzheimers Dis，2014，40（2）：297-308.
[24]	Song JH，Marszalec W，Kai L，et al.Antidepressants inhibit proton currents and tumor necrosis factor-α production in BV2 microglial cells[J].Brain Res，2012，1435：15-23.
[29]	Fang KM，Yang CS，Lin TC，et al.Induced interleukin-33 expression enhances the tumorigenic activity of rat glioma cells[J].Neuro Oncol，2014，16（4）：552-566.